Holen Sie sich die Stockscreener-App
35.15
1.15%
0.40
Handel nachbörslich:
35.31
0.16
+0.46%
Schlusskurs vom Vortag:
$34.75
Offen:
$35.15
24-Stunden-Volumen:
2.43M
Relative Volume:
0.95
Marktkapitalisierung:
$5.53B
Einnahmen:
$640.44M
Nettoeinkommen (Verlust:
$-743.28M
KGV:
-3.1137
EPS:
-11.2888
Netto-Cashflow:
$-206.93M
1W Leistung:
-6.32%
1M Leistung:
-9.76%
6M Leistung:
-11.79%
1J Leistung:
+0.00%
1-Tages-Spanne:
$34.35
$35.93
1-Wochen-Bereich:
$31.36
$37.50
52-Wochen-Spanne:
$22.89
$79.49
Tempus Ai Inc Stock (TEM) Company Profile
Firmenname
Tempus Ai Inc
Sektor
Branche
Telefon
800-976-5448
Adresse
600 WEST CHICAGO AVENUE, CHICAGO
Vergleichen Sie TEM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
35.15 | 5.53B | 640.44M | -743.28M | -206.93M | -11.29 |
|
VEEV
Veeva Systems Inc
|
216.59 | 35.16B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
73.51 | 12.70B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
53.72 | 10.03B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
102.42 | 8.88B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.47 | 6.45B | 906.14M | -52.62M | 89.62M | -0.3621 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2024-12-09 | Eingeleitet | Guggenheim | Buy |
| 2024-11-11 | Herabstufung | Stifel | Buy → Hold |
| 2024-10-02 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-08-12 | Eingeleitet | Piper Sandler | Neutral |
| 2024-07-09 | Eingeleitet | BofA Securities | Buy |
| 2024-07-09 | Eingeleitet | JP Morgan | Overweight |
| 2024-07-09 | Eingeleitet | Longbow | Buy |
| 2024-07-09 | Eingeleitet | Loop Capital | Buy |
| 2024-07-09 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-07-09 | Eingeleitet | Needham | Buy |
| 2024-07-09 | Eingeleitet | Stifel | Buy |
| 2024-07-09 | Eingeleitet | TD Cowen | Buy |
| 2024-07-09 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Tempus Ai Inc Aktie (TEM) Neueste Nachrichten
Tempus AI shares set to rally as Pelosi buys calls - Investing.com
Tempus AI, Inc. Majority Shareholder Sells $33M Worth of Stock - The Africa Logistics
Tempus AI, Inc : Good timing to go long again -January 20, 2025 at 11:06 am EST - Marketscreener.com
Tempus AI announces national launch of FDA-approved xT CDx test - MSN
TEM Insider Trade Alert! Majority Shareholder Sells $33M Worth of Tempus AI Stock - TipRanks
Avanza Fonder AB Purchases Shares of 35,414 Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat
Tempus AI's Bradley Keywell sells $33.1 million in stock - MSN
Tempus AI Stock Plunges 28.9% in Three Months: What's Next? - MSN
Tempus AI Inc (TEM): AI-Driven Healthcare Revolution - Insider Monkey
10 Must-Watch AI Stocks on Investors’ Radar - Insider Monkey
Cathie Wood's Ark Invest Is Betting Big On This AI Darling And No It's Not Nvidia - Benzinga
Tempus AI, Inc. (NASDAQ:TEM) Major Shareholder Bradley A. Keywell Sells 265,000 Shares - MarketBeat
Insider Selling: Tempus AI, Inc. (NASDAQ:TEM) Major Shareholder Sells 170,720 Shares of Stock - MarketBeat
Tempus AI's Bradley Keywell sells $33.1 million in stock By Investing.com - Investing.com Australia
Tempus AI (NASDAQ:TEM) Shares Up 11.7%Should You Buy? - MarketBeat
30,486 Shares in Tempus AI, Inc. (NASDAQ:TEM) Acquired by Bouvel Investment Partners LLC - MarketBeat
Tempus AI, Inc. Announces the National Launch of FDA-Approved xT CDx Test -January 15, 2025 at 08:30 am EST - Marketscreener.com
Tempus AI, Inc. (NASDAQ:TEM) Short Interest Update - MarketBeat
Tempus AI Leads Wednesday’s Rally with FDA-Approved Diagnostic Device Launch – Market - HPBL
Why Tempus AI (TEM) Is Among Wednesday’s Top Gainers? - MSN
Tempus AI (NASDAQ:TEM) Stock Price Down 7.9%Should You Sell? - MarketBeat
Tempus AI (NASDAQ:TEM) Stock Price Up 11.7%Still a Buy? - MarketBeat
Tempus AI Shares Rise on Launch of Cancer-Profiling Device - MarketWatch
Tempus AI (NASDAQ:TEM) Shares Gap DownShould You Sell? - MarketBeat
Tempus Announces the National Launch of FDA-Approved xT CDx Test - Marketscreener.com
Tempus AI Launches FDA-Approved 648-Gene Cancer Diagnostic Test Nationwide - StockTitan
Tempus AI: Disappointing Q4 Preliminary Results, But Bullish Fundamental Update - Seeking Alpha
Tempus AI shares rated Buy by Loop Capital, target cut as Compass CRO softness weighs on guidance - Investing.com Canada
TEM Stock Declines Following Preliminary Q4 Sales Miss - MSN
Tempus announces preliminary fourth quarter revenue, shares fall - MSN
Tempus AI (TEM) Launches AI-Powered Whole-Genome Sequencing Test to Transform Precision Medicine - Insider Monkey
15 Important AI News and Ratings on Investors’ Radar - Insider Monkey
Loop Capital Has Lowered Expectations for Tempus AI (NASDAQ:TEM) Stock Price - MarketBeat
JPM25, Day 2: News from Nvidia, Tempus AI and Health Catalyst; A look at Children's Health Dallas' expansion plans - Fierce healthcare
Needham & Company LLC Reiterates "Buy" Rating for Tempus AI (NASDAQ:TEM) - MarketBeat
Tempus AI Revolutionizes Healthcare with Advanced Generative AI Platform Upgrade - StockTitan
Beyond The Numbers: 6 Analysts Discuss Tempus AI Stock - Benzinga
Lefkofsky, touting strong financials for Tempus, paints a rosy future for AI and medicine - Crain's Chicago Business
Cathie Wood's ARK Snaps Up Tempus AI Shares Despite Revenue Miss and Market Sell-Off - GuruFocus.com
Cathie Wood’s ARKG Loads Up on Tempus AI (NASDAQ:TEM) as Stock Plunges on Revenue Miss - TipRanks
Here’s Why Tempus AI, Inc (TEM) Is Among Monday’s Top Losers - MSN
Cathie Wood's Ark Invest Trims Palantir Again As Peter Thiel Co-Founded Firm's Stock Tumbles Nearly 15% In 2025 - Benzinga
SB TEMPUS Signs Agreement with Konica Minolta To Acquire Shares of Konica Minolta REALM - Konica Minolta
10 Firms Drop on Bearish Statements, Disappointing Earnings - Insider Monkey
Tempus AI unveils whole-genome sequencing test for cancer By Investing.com - Investing.com Canada
Tempus AI Reports Preliminary 2024 Revenue of $693 Million, Shares Fall Over 14% - Yahoo Finance
Tempus AI reports 30% annual revenue growth in 2024 By Investing.com - Investing.com Australia
Tempus AI Shares Fall 11.7% After 4Q Revenue Projections Fall Below Expectations - MarketWatch
Tempus AI reports 30% annual revenue growth in 2024 - Investing.com
Finanzdaten der Tempus Ai Inc-Aktie (TEM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.29%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):